346 related articles for article (PubMed ID: 8603767)
21. Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.
Launay B; Zinman B; Tildesley HD; Strack T; Chiasson JL
Diabetes Care; 1998 Oct; 21(10):1627-31. PubMed ID: 9773721
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass.
Pørksen NK; Munn SR; Steers JL; Schmitz O; Veldhuis JD; Butler PC
Diabetes; 1996 Dec; 45(12):1792-7. PubMed ID: 8922367
[TBL] [Abstract][Full Text] [Related]
23. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans.
Meier JJ; Veldhuis JD; Butler PC
Diabetes; 2005 Jun; 54(6):1649-56. PubMed ID: 15919785
[TBL] [Abstract][Full Text] [Related]
24. Evidence that insulin can directly inhibit hepatic glucose production.
Maheux P; Chen YD; Polonsky KS; Reaven GM
Diabetologia; 1997 Nov; 40(11):1300-6. PubMed ID: 9389422
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
26. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.
Banarer S; McGregor VP; Cryer PE
Diabetes; 2002 Apr; 51(4):958-65. PubMed ID: 11916913
[TBL] [Abstract][Full Text] [Related]
27. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
[TBL] [Abstract][Full Text] [Related]
28. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.
Robert JJ; Chauvet D; Darmaun D; Leblanc H
Diabetologia; 1993 Nov; 36(11):1185-90. PubMed ID: 8270134
[TBL] [Abstract][Full Text] [Related]
29. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM.
Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD
Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592
[TBL] [Abstract][Full Text] [Related]
30. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
[TBL] [Abstract][Full Text] [Related]
31. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.
Turk D; Alzaid A; Dinneen S; Nair KS; Rizza R
J Clin Invest; 1995 Feb; 95(2):755-62. PubMed ID: 7860757
[TBL] [Abstract][Full Text] [Related]
32. Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs.
McCall RH; Wiesenthal SR; Shi ZQ; Polonsky K; Giacca A
Am J Physiol; 1998 Feb; 274(2):E346-56. PubMed ID: 9486168
[TBL] [Abstract][Full Text] [Related]
33. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
Ader M; Bergman RN
Am J Physiol; 1990 Jun; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
[TBL] [Abstract][Full Text] [Related]
34. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.
Guan J; Zucker PF; Behme MT; Zhong R; Atkinson P; Dupré J
Diabetes; 1997 Mar; 46(3):372-8. PubMed ID: 9032091
[TBL] [Abstract][Full Text] [Related]
36. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
[TBL] [Abstract][Full Text] [Related]
37. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
38. Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia.
Gupta N; Sandhu H; Goh T; Shah K; Wiesenthal SR; Yoshii H; Chong V; Lam TK; Haber CA; Williams W; Tchipashvili V; Giacca A
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1002-7. PubMed ID: 12376328
[TBL] [Abstract][Full Text] [Related]
39. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
Sindelar DK; Chu CA; Rohlie M; Neal DW; Swift LL; Cherrington AD
Diabetes; 1997 Feb; 46(2):187-96. PubMed ID: 9000693
[TBL] [Abstract][Full Text] [Related]
40. Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content.
Freyse EJ; Rebrin K; Schneider T; Petrzika M; Fischer U
Diabetes; 1996 May; 45(5):667-74. PubMed ID: 8621020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
